alexa Yoh Dobashi
ISSN: 2167-7700

Chemotherapy: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Yoh Dobashi

Department of Pathology
Saitama Medical Center
Jichi Medical University
Saitama, Japan

 Yoh Dobashi, graduated from Medical School in 1984, and Graduate School at Gunma University, Gunma, Japan, afterward. After the Hospital Residency and Research Fellowship in Yale University School of Medicine, USA, he has worked as Assistant Professor at the Department of Pathology, Faculty of Medicine, University of Tokyo until 1990. He has got involved in basic research for 3 years in Osaka University, moved to Department of Pathology, Kitasato University School of Medicine. Since 2006, he has been working in Department of Pathology, Saitama Medical Center, Jichi Medical University.  His major is pathological diagnosis and cell biology of lung cancer.

Research Interest

Cancer Cell Biology

Cell Signaling

Tumor Markers

Pathological diagnosis

 Cell biology of lung cancer



Molecularly Targeted Therapy: Past, Present and Future

Yoh Dobashi, Akiteru Goto, Maiko Kimura and Tomoyuki Nakano

Review Article: Chemotherapy 2012, 1:105

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version